W. P. Carey Inc.: Form 10-Q for the period ended Sep 30, 2023
Filed with the SEC on Nov 3, 2023 and accepted by EDGAR at Nov 3, 2023, 16:24 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-07-01 to 2023-09-30 | $448.6m | us-gaap:Revenues |
| Revenue | 9 months2023-01-01 to 2023-09-30 | $1.33bn | us-gaap:Revenues |
| Cost of revenue | 3 months2023-07-01 to 2023-09-30 | $97.0k | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2023-01-01 to 2023-09-30 | $322.0k | us-gaap:CostOfRevenue |
| Interest expense | 3 months2023-07-01 to 2023-09-30 | $77.0m | us-gaap:InterestExpense |
| Interest expense | 9 months2023-01-01 to 2023-09-30 | $219.7m | us-gaap:InterestExpense |
| Income tax | 3 months2023-07-01 to 2023-09-30 | $5.1m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2023-01-01 to 2023-09-30 | $30.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-07-01 to 2023-09-30 | $125.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2023-01-01 to 2023-09-30 | $564.0m | us-gaap:NetIncomeLoss |
| Diluted shares (weighted) | 3 months2023-07-01 to 2023-09-30 | 215,252,969 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2023-01-01 to 2023-09-30 | 214,427,425 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2023-01-01 to 2023-09-30 | $812.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 9 months2023-01-01 to 2023-09-30 | $686.2m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2023-09-30 | $136.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | At period end2023-09-30 | $18.63bn | us-gaap:Assets |
| Total liabilities | At period end2023-09-30 | $9.48bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-09-30 | $8.29bn | us-gaap:LongTermDebt |
| Shareholders' equity | At period end2023-09-30 | $9.13bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001628280-23-036734. Last ingested by Listed: Oct 27, 2026, 16:14 ET. Listed shows no prices and gives no investment advice.